Atherosclerosis, the formation of fibrofatty lesions in the artery wall, causes much morbidity
and mortality worldwide, including most myocardial infarctions and many strokes, as well as …

European guidelines on cardiovascular prevention in clinical practice were first published in
1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint …

Background Some autoimmune diseases are associated with an increased risk of
cardiovascular disease. We aimed to determine whether or not this is true, and to what …

Background and aim: Chronic low-grade inflammation is associated with various health
outcomes, including cardiovascular diseases (CVDs) and cancers. Systemic immune …

Níveis de evidência Nível A Dados obtidos a partir de múltiplos estudos randomizados de
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …

Background The causes for immune-mediated inflammatory diseases (IMIDs) are diverse
and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to …

Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …

Objective To determine associations of BNT162b2 vaccination with SARS-CoV-2 infection
and hospital admission and death with covid-19 among nursing home residents, nursing …

712 Stroke March 2020 outcome of stroke. 27, 28 Rosuvastatin reduced stroke risk in
subjects who either achieved LDL-C levels of< 70 mg/dL or hs-CRP levels of< 2 mg/L …

Despite an overall reduction in cardiovascular disease (CVD) mortality in the USA, the rate
of coronary heart disease and CVD mortality is on the rise in younger women aged 35 to 54 …